ReviewCancer management and research2026

CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing.

Jiadi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.